These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 8137876

  • 1. Differential effects of selective tachykinin NK2 receptor antagonists in rat spinal cord.
    Wiesenfeld-Hallin Z, Luo L, Xu XJ, Maggi CA.
    Eur J Pharmacol; 1994 Jan 04; 251(1):99-102. PubMed ID: 8137876
    [Abstract] [Full Text] [Related]

  • 2. Low-dose intrathecal clonidine releases tachykinins in rat spinal cord.
    Luo L, Wiesenfeld-Hallin Z.
    Eur J Pharmacol; 1993 Apr 22; 235(1):157-9. PubMed ID: 7686104
    [Abstract] [Full Text] [Related]

  • 3. The effects of pretreatment with tachykinin antagonists and galanin on the development of spinal cord hyperexcitability following sciatic nerve section in the rat.
    Luo L, Wiesenfeld-Hallin Z.
    Neuropeptides; 1995 Mar 22; 28(3):161-6. PubMed ID: 7540733
    [Abstract] [Full Text] [Related]

  • 4. On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat.
    Xu XJ, Maggi CA, Wiesenfeld-Hallin Z.
    Neuroscience; 1991 Mar 22; 44(2):483-90. PubMed ID: 1719450
    [Abstract] [Full Text] [Related]

  • 5. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ, Naeem S, Patel IA, Walpole C, Urbán L.
    Acta Biol Hung; 1996 Mar 22; 47(1-4):129-44. PubMed ID: 9123986
    [Abstract] [Full Text] [Related]

  • 6. Physiological and pharmacological characterization of the spinal tachykinin NK2 receptor.
    Lepre M, Olpe HR, Evans RH, Brugger F.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):23-31. PubMed ID: 7523150
    [Abstract] [Full Text] [Related]

  • 7. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
    Picard P, Boucher S, Regoli D, Gitter BD, Howbert JJ, Couture R.
    Eur J Pharmacol; 1993 Mar 02; 232(2-3):255-61. PubMed ID: 7682180
    [Abstract] [Full Text] [Related]

  • 8. Spasmolytic effect of the NK2-receptor-selective antagonist MEN 10,627 in rat small intestine.
    Tramontana M, Maggi CA, Evangelista S.
    Jpn J Pharmacol; 1994 Jul 02; 65(3):281-3. PubMed ID: 7799529
    [Abstract] [Full Text] [Related]

  • 9. Spinal NK2 receptors contribute to the increased excitability of the nociceptive flexor reflex during persistent peripheral inflammation.
    Jia YP, Seybold VS.
    Brain Res; 1997 Mar 14; 751(1):169-74. PubMed ID: 9098584
    [Abstract] [Full Text] [Related]

  • 10. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA, Patacchini R, Eglezos A, Quartara L, Giuliani S, Giachetti A.
    Br J Pharmacol; 1992 Sep 14; 107(1):27-33. PubMed ID: 1384907
    [Abstract] [Full Text] [Related]

  • 11. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones.
    Ma QP, Woolf CJ.
    J Physiol; 1995 Aug 01; 486 ( Pt 3)(Pt 3):769-77. PubMed ID: 7473237
    [Abstract] [Full Text] [Related]

  • 12. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
    Tschöpe C, Picard P, Culman J, Prat A, Itoi K, Regoli D, Unger T, Couture R.
    Br J Pharmacol; 1992 Nov 01; 107(3):750-5. PubMed ID: 1335337
    [Abstract] [Full Text] [Related]

  • 13. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 14. Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.
    Chizh BA, Cumberbatch MJ, Birch PJ, Headley PM.
    Br J Pharmacol; 1995 Jul 07; 115(6):1013-9. PubMed ID: 7582497
    [Abstract] [Full Text] [Related]

  • 15. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R, Quartara L, Rolka K, Zboinska J, Kupryszewski G, Maggi CA.
    Eur J Pharmacol; 1993 Dec 07; 250(2):311-6. PubMed ID: 7509285
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of tachykinin receptor antagonists on thermally induced inflammatory reactions in a rat model.
    Löfgren O, Qi Y, Lundeberg T.
    Burns; 1999 Mar 07; 25(2):125-9. PubMed ID: 10208386
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation.
    Xu XJ, Dalsgaard CJ, Wiesenfeld-Hallin Z.
    Eur J Pharmacol; 1992 Jun 17; 216(3):337-44. PubMed ID: 1385160
    [Abstract] [Full Text] [Related]

  • 18. Intrathecal administration of neurokinin 1 and neurokinin 2 receptor antagonists undermines the savings effect in spinal rats seen in an instrumental learning paradigm.
    Baumbauer KM, Young EE, Hoy KC, Joynes RL.
    Behav Neurosci; 2007 Feb 17; 121(1):186-99. PubMed ID: 17324063
    [Abstract] [Full Text] [Related]

  • 19. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
    Yashpal K, Hui-Chan CW, Henry JL.
    Eur J Pharmacol; 1996 Jul 11; 308(1):41-8. PubMed ID: 8836630
    [Abstract] [Full Text] [Related]

  • 20. Effect of newly developed tachykinin agonist and antagonists on the guinea pig isolated gallbladder.
    Patacchini R, Maggi CA.
    J Pharmacol Exp Ther; 1992 Apr 11; 261(1):191-4. PubMed ID: 1313868
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.